← Latest papers
📄 medicine

Longitudinal Pulmonary Function Progression and Risk of New-Onset Airflow Obstruction in SAD and PRISm: a Multi-Center Population-Based Cohort Study in Southwest China

This multi-center population-based cohort study in Southwest China demonstrates that small-airway dysfunction (SAD) and preserved-ratio impaired spirometry (PRISm), particularly when co-occurring, are significant independent predictors of incident airflow obstruction and distinct longitudinal pulmonary function decline, highlighting their utility as early screening markers despite the need for clinical confirmation.

Original authors: Yuepeng Li, Chuping Chen, Yi Lei, Rui Zhang, Weimin Li

Published 2026-10-23
📖 5 min read🧠 Deep dive

Original authors: Yuepeng Li, Chuping Chen, Yi Lei, Rui Zhang, Weimin Li

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ✨ This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer

The human lungs are a resilient organ, capable of adapting to years of exposure to dust, smoke, and pollution before showing obvious signs of distress. For decades, doctors have relied on a single, critical measurement to diagnose chronic obstructive pulmonary disease, or COPD: a test that measures how much air a person can force out of their lungs in one second compared to the total amount they can exhale. When this ratio drops below a specific threshold, the diagnosis is clear. However, science has long suspected that the road to this diagnosis is not a sudden cliff but a long, winding path. Before the airways become permanently blocked, there are subtle warning signs. Two such signs have recently come into focus. One is a condition where the total volume of air a person can exhale is lower than expected, even though the ratio of fast air to total air remains normal; this is known as preserved-ratio impaired spirometry. The other is a dysfunction in the tiny, narrow tubes deep inside the lungs that carry air, which can be detected by how quickly air flows out in the middle and end of a breath, even if the main lung volumes look healthy. These early markers are not diseases in themselves, but they may signal that a person is walking a path toward future breathing problems. Understanding who is most likely to develop these problems, and how quickly, could allow communities to intervene before permanent damage occurs.

A large team of researchers in Southwest China set out to map this path using data from over ten thousand adults who participated in community lung health screenings. The study, conducted across three different towns, followed these individuals over time, giving them repeated lung function tests to see how their breathing changed. The researchers were particularly interested in sorting people into distinct groups based on their initial test results. They identified those with perfectly normal lungs, those with only the subtle deep-airway issues, those with the low-volume but normal-ratio pattern, those with both patterns combined, and those who already had the classic signs of airflow obstruction. By tracking who developed new breathing problems over the course of the study, the team could calculate the risk associated with each starting point.

The results revealed a clear hierarchy of risk. People who started with completely normal lung function had a very low chance of developing new airflow obstruction during the study period. However, those who began with the subtle deep-airway dysfunction faced a significantly higher risk. The danger was even more pronounced for those who showed the low-volume pattern combined with deep-airway dysfunction. While the group with the low-volume pattern alone showed a high rate of new obstruction, this estimate was based on only 24 participants and 2 events, making it highly imprecise. Most notably, the group that exhibited both the deep-airway dysfunction and the low-volume pattern together faced the highest confirmed risk of all. In fact, among those who started with this combined pattern, more than one in five developed new airflow obstruction by the end of the follow-up period. This was a stark contrast to the normal group, where fewer than one in a hundred developed the condition. The study also confirmed that being male and a current smoker increased the likelihood of developing these problems, regardless of the starting lung pattern.

The researchers also looked at how lung function changed year by year. For most groups, including those with normal lungs and those with the deep-airway issues, the amount of air they could exhale in one second naturally decreased with age, which is an expected part of growing older. Interestingly, the group with the combined low-volume and deep-airway issues showed a different pattern. Their lung function did not decline as rapidly as the others during the study period, but this was likely because they started with such low lung volumes that there was less room to fall further, or because the measurement methods made it difficult to see small changes. The key takeaway was not that their lungs were improving, but that they were already operating with less reserve and were at the greatest immediate risk of crossing the line into a formal diagnosis of obstruction.

This study provides a crucial map for community health programs. It suggests that when a screening test reveals these subtle, early warning signs, it should not be ignored, but it also should not be treated as a final diagnosis. A person with these early markers is not yet sick with COPD, but they are on a trajectory that requires attention. The findings indicate that the combination of these two early signs is a powerful predictor of future trouble. The researchers emphasize that these results are based on screening tests, which can sometimes vary due to how well a person performs the breathing maneuver on a given day. Therefore, these early signs should trigger a conversation about risk factors, such as smoking or exposure to pollution, and lead to repeat testing to confirm the findings. The goal is to identify individuals who need closer monitoring and support to stop smoking or reduce exposure to harmful air, potentially slowing or preventing the progression to permanent lung disease. The study concludes that while these early patterns are valuable for spotting risk, they are not a substitute for a clinical diagnosis, and larger studies with more detailed confirmatory testing are needed before these findings can be turned into standard medical practice.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →